ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 19 filers reported holding ACURX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116 | -32.6% | 77 | +18.5% | 0.00% | – |
| Q2 2023 | $172 | -20.0% | 65 | +4.8% | 0.00% | – |
| Q1 2023 | $215 | -11.5% | 62 | +1.6% | 0.00% | – |
| Q4 2022 | $243 | – | 61 | +5.2% | 0.00% | – |
| Q3 2022 | $0 | – | 58 | +222.2% | 0.00% | – |
| Q2 2022 | $0 | – | 18 | +12.5% | 0.00% | – |
| Q1 2022 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 16 | +6.7% | 0.00% | – |
| Q3 2021 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Draper Asset Management, LLC | 266,025 | $873,000 | 0.72% |
| Patriot Financial Group Insurance Agency, LLC | 9,750 | $32,000 | 0.01% |
| Semmax Financial Advisors Inc. | 1,263 | $4,000 | 0.00% |
| TD Waterhouse Canada Inc. | 30,000 | $102,300 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,941 | $35,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 10,100 | $33,000 | 0.00% |
| BlackRock Inc. | 16,699 | $55,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,319 | $11,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16 | $0 | 0.00% |